Cardiff Oncology, Inc. (CRDF)

Cardiff Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	55	192	289	66	63	252
Market Cap Growth	-79.14%	-33.52%	336.64%	5.71%	-75.20%	-61.88%
Enterprise Value	8.28	134.47	198.49	-6.55	-40	114.5
Last Close Price	0.81	2.81	4.34	1.48	1.40	6.01

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PS Ratio	102.27	323.67	422.72	135.50	162.04	702.52
PB Ratio	1.61	4.23	3.48	0.95	0.59	1.80
P/TBV Ratio	1.56	4.14	2.49	0.95	0.57	1.67

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	15.77	226.75	290.62	-13.43	-103.64	318.95
EV/EBITDA Ratio	-	-	-	0.15	1.01	-
EV/EBIT Ratio	-	-	-	0.14	1.00	-
EV/FCF Ratio	-	-	-	0.21	1.15	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	-	0.00	0.01	0.02	0.02	0.02
Net Debt / Equity Ratio	-1.31	-1.27	-1.09	-1.04	-0.96	-0.98
Net Debt / EBITDA Ratio	0.97	1.18	1.87	1.61	2.59	4.85
Net Debt / FCF Ratio	1.21	1.51	2.39	2.31	2.95	5.92
Asset Turnover	0.01	0.01	0.01	0.00	0.00	0.00
Quick Ratio	3.20	3.57	6.89	7.19	13.58	21.55
Current Ratio	3.27	3.67	7.08	7.41	14.25	22.28
Return on Equity (ROE)	-111.77%	-71.45%	-59.51%	-47.07%	-31.37%	-21.07%
Return on Assets (ROA)	-85.41%	-61.56%	-54.41%	-45.91%	-30.03%	-20.30%
Return on Invested Capital (ROIC)	-1911.65%	-1836.46%	-1253.57%	-865.15%	-835.64%	-930.96%
Return on Capital Employed (ROCE)	-118.28%	-75.76%	-62.79%	-50.58%	-31.75%	-21.25%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Buyback Yield / Dilution	-26.71%	-40.27%	-6.65%	-2.47%	-11.71%	-86.97%
Total Shareholder Return	-26.71%	-40.27%	-6.65%	-2.47%	-11.71%	-86.97%

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: May 14, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 29, 2026

Data Sources Report a data error